The pharmaceutical industry in New Zealand has voiced its opposition to moves by the country's health minister Annette King to harmonise direct-to-consumer (DTC) advertising laws with those of Australia,

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.452, 2004-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Almost all physicians in Finland are against complete direct-to-consumer (DTC) advertising of prescription drugs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 457, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

DTC advertising under review in New Zealand

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 291, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Direct-to-consumer (DTC) advertising of rofecoxib [Vioxx] and celecoxib [Celebrex] increased the number of patients with osteoarthritis (OA) seen by physicians each month

By  

Inpharma, Vol. 1, Iss. 1571, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

In the year to March 2002, spending on direct-to-consumer (DTC) advertising for a single product in the US was highest for AstraZeneca's esomeprazole [`Nexium'] at $US177 million

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 398, 2003-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Direct-to-consumer (DTC) advertising of rofecoxib [Vioxx] and celecoxib [Celebrex] increased the number of patients with osteoarthritis (OA) seen by physicians each month

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 519, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite